An Enflammatory Marker in Chronic Renal Failure Patients: Visfatin
PDF
Cite
Share
Request
Original Article
P: 187-191
September 2015

An Enflammatory Marker in Chronic Renal Failure Patients: Visfatin

Med Bull Haseki 2015;53(3):187-191
1. Uludağ Üniversitesi Tıp Fakültesi, Nefroloji Anabilim Dalı, Bursa, Türkiye
2. Uludağ Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Bursa, Türkiye
3. Uludağ Üniversitesi Tıp Fakültesi, Radyoloji Anabilim Dalı, Bursa, Türkiye
4. Uludağ Üniversitesi Tıp Fakültesi, Tıbbi Biokimya Anabilim Dalı, Bursa, Türkiye
No information available.
No information available
Received Date: 13.08.2014
Accepted Date: 24.11.2014
PDF
Cite
Share
Request

ABSTRACT

Aim:

Visfatin is a cytokine released from adipose tissue, especially in enflammation. In our study, we tried to show the relationship of visfatin levels with chronic renal failure (CRF) as an enflammatory marker.

Methods:

We included 50 CRF patients (28 male, 22 female) who attended Uludağ University Nephrology Clinic and 31 healthy volunteers (13 male, 18 female). Visfatin levels and biochemical parameters, such as parathyroid hormone (PTH), lipid parameters, albumin, C-reactive protein (CRP), creatinine, urea, immunoglobulins, etc. were examined.

Results:

In CRF patients, visfatin levels were found to be significantly increased (p<0.001) and albumin, hemoglobin, body mass index (BMI) and high density lipoprotein (HDL) cholesterol levels were decreased (p<0.001). Triglycerides (p=0.003), CPR (p=0.005), procalcitonin (p<0.001), IgG3 (p=0.003), and ferritin (p<0.001) levels were significantly higher in patient group than in control group as an enflammatory marker.

Conclusion:

CRF is an independent enflammatory process. Visfatin levels in patients with chronic renal failure patients are determined to be high as an indicator of enflammation.